Effectiveness of angiotensin-converting enzyme inhibitors in pediatric patients with mid to severe aortic valve regurgitation

Pediatric Cardiology

Volumn 29, Issue 5, 2008, Pages 906-909

  Gisler, Fabian ^a   Knirsch, Walter ^a   Harpes, Paul ^b   Bauersfeld, Urs ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Angiotensin converting enzyme inhibitor; Aortic valve regurgitation; Echocardiography

Indexed keywords

CAPTOPRIL; ENALAPRIL;

AORTA VALVE REGURGITATION; ARTICLE; CHILD; CHILD CARE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ECHOCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE WALL; HEART VENTRICLE FUNCTION; HUMAN; QUANTITATIVE ANALYSIS; SCORING SYSTEM; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AORTIC VALVE INSUFFICIENCY; CHILD; CHILD, PRESCHOOL; DILATATION, PATHOLOGIC; HEART VENTRICLES; HUMANS; RETROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 50649124211     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-008-9228-x     Document Type: Article

References (23)

1. D Alehan S Ozkutlu 1998 Beneficial effects of 1-year captopril therapy in children with chronic aortic regurgitation who have no symptoms Am Heart J 135 598 603
2. R Bekeredjian PA Grayburn 2005 Valvular heart disease: aortic regurgitation Circulation 112 125 134
3. RO Bonow B Carabello AC de Leon Jr LH Edmunds Jr BJ Fedderly MD Freed WH Gaasch CR McKay RA Nishimura PT O'Gara RA O'Rourke SH Rahimtoola JL Ritchie MD Cheitlin KA Eagle TJ Gardner A Garson Jr RJ Gibbons RO Russell TJ Ryan SC Smith Jr 1998 Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease) Circulation 98 1949 1984
4. RO Bonow E Lakatos BJ Maron SE Epstein 1991 Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function Circulation 84 1625 1635
5. Brunton L (2006) Goodman and Gilman's the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, Medical Publishing Division, New York
6. BA Carabello 1990 Aortic regurgitation. A lesion with similarities to both aortic stenosis and mitral regurgitation Circulation 82 1051 1053
7. BA Carabello 2005 Vasodilators in aortic regurgitation-Where is the evidence of their effectiveness? N Engl J Med 353 1400 1402
8. JN Cohn R Ferrari N Sharpe 2000 Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling J Am Coll Cardiol 35 569 582
9. D Du Bois EF Du Bois 1989 A formula to estimate the approximate surface area if height and weight be known. 1916 Nutrition 5 303 311 discussion 312-313
10. A Evangelista HG del Castillo F Calvo G Permanyer-Miralda C Brotons J Angel T Gonzalez-Alujas P Tornos J Soler-Soler 2000 Strategy for optimal aortic regurgitation quantification by Doppler echocardiography: agreement among different methods Am Heart J 139 773 781
11. A Evangelista P Tornos A Sambola G Permanyer-Miralda J Soler-Soler 2005 Long-term vasodilator therapy in patients with severe aortic regurgitation N Engl J Med 353 1342 1349
12. C Kampmann CM Wiethoff A Wenzel G Stolz M Betancor CF Wippermann RG Huth P Habermehl M Knuf T Emschermann H Stopfkuchen 2000 Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe Heart 83 667 672
13. RM Lang M Bierig RB Devereux FA Flachskampf E Foster PA Pellikka MH Picard MJ Roman J Seward JS Shanewise SD Solomon KT Spencer MS Sutton WJ Stewart 2005 Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 1440 1463
14. HJ Levine WH Gaasch 1996 Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves J Am Coll Cardiol 28 1083 1091
15. M Lin HT Chiang SL Lin MS Chang BN Chiang HW Kuo MD Cheitlin 1994 Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy J Am Coll Cardiol 24 1046 1053
16. BS Moffett AC Chang 2006 Future pharmacologic agents for treatment of heart failure in children Pediatr Cardiol 27 533 551
17. K Momma 2006 ACE inhibitors in pediatric patients with heart failure Paediatr Drugs 8 55 69
18. Y Mori M Nakazawa H Tomimatsu K Momma 2000 Long-term effect of angiotensin-converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study J Am Coll Cardiol 36 270 275
19. C Pisacane G Pacileo G Santoro B Sarubbi C Iacono MG Russo R Calabro 2001 New insights in the pathophysiology of mitral and aortic regurgitation in pediatric age: role of angiotensin-converting enzyme inhibitor therapy Ital Heart J 2 100 106
20. SN Reske I Heck J Kropp H Mattern R Ledda R Knopp C Winkler 1985 Captopril mediated decrease of aortic regurgitation Br Heart J 54 415 419
21. HR Schon 1994 Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation J Hypertens Suppl 12 S95 S104
22. R Scognamiglio SH Rahimtoola G Fasoli S Nistri S Dalla Volta 1994 Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function N Engl J Med 331 689 694
23. WA Zoghbi M Enriquez-Sarano E Foster PA Grayburn CD Kraft RA Levine P Nihoyannopoulos CM Otto MA Quinones H Rakowski WJ Stewart A Waggoner NJ Weissman 2003 Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 16 777 802